News

Two neglected tropical illnesses, lymphatic filariasis and onchocerciasis, will receive a combined investment of about 790-million-yen ($5.3 million) from the Global Health Innovative Technology (GHIT) Fund in Japan. The parasitic worms that cause lymphatic filariasis, also known as elephantiasis, and...

The Clinical Trials Environmental Impact Community of Interest (CoI), a cooperative effort that aims to determine the carbon footprint of centralised and decentralised clinical trials, has been launched by The Pistoia Alliance, a non-profit organisation that promotes R&D collaboration...

Seven CEOs of pharmaceutical companies, including GSK, AstraZeneca, Merck, Roche, Novo Nordisk, Samsung Biologics, and Sanofi, have launched a collaborative effort to meet short-term emission reduction goals and hasten the implementation of net zero health systems. The Sustainable Markets Initiative (SMI) Health...

The majority of consumers base their first impression of a business and its sustainability credentials on the product packaging. With a third of UK consumers prepared to pay more for sustainable goods and services, the distinction between single-use, non-recyclable, and...

According to a market analysis, the global oral solid dosage (OSD) contract manufacturing market is forecast to grow $54.7 billion in value by 2030, growing at a compound annual growth rate (CAGR) of 6%. Oral solids are the most popular...

The growth of the domestic pharmaceutical industry and a reduction in reliance on imports might be facilitated by funding AI-based research and development and focusing on the key diseases that impact people in Africa, experts suggested at a recent...

A new cold chain facility being built by Etihad Cargo, Etihad Airport Services, and Abu Dhabi Airports will more than increase the carrier's pharmaceutical capability at the airport's cargo village. For Etihad Cargo's PharmaLife handling and storage operations, the new...